Home Cart Sign in  
Chemical Structure| 443797-96-4 Chemical Structure| 443797-96-4

Structure of JNJ-7706621
CAS No.: 443797-96-4

Chemical Structure| 443797-96-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

JNJ-7706621 is a pan-CDK inhibitor that inhibits CDK1/2 with IC50 of 9/4 nM, also potently inhibits Aurora A/B.

Synonyms: Aurora A Inhibitor I; Aurora Kinase/CDK Inhibitor

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of JNJ-7706621

CAS No. :443797-96-4
Formula : C15H12F2N6O3S
M.W : 394.36
SMILES Code : NC1=NC(NC2=CC=C(C=C2)S(N)(=O)=O)=NN1C(=O)C1=C(F)C=CC=C1F
Synonyms :
Aurora A Inhibitor I; Aurora Kinase/CDK Inhibitor
MDL No. :MFCD11100270
InChI Key :KDKUVYLMPJIGKA-UHFFFAOYSA-N
Pubchem ID :5330790

Safety of JNJ-7706621

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of JNJ-7706621

epigenetics
DNA
Hedgehog

Isoform Comparison

Biological Activity

Target
  • Aurora A

    Aurora A, IC50:11 nM

  • Aurora B

    Aurora B, IC50:15 nM

  • CDK4

    CDK4/CyclinD1, IC50:253 nM

  • CDK2

    CDK2/CyclinE, IC50:3 nM

    CDK2/CyclinA, IC50:4 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
U-2932 cells 500 nM 144 hours To investigate the effects of JNJ-7706621 in combination with 177Lu-lilotomab satetraxetan on cell cycle and cell death in U-2932 cells. Results showed that combination treatment significantly increased cell death and formation of multinucleated cells. PMC6897291
RIVA cells 500 nM 144 hours To investigate the effects of JNJ-7706621 in combination with 177Lu-lilotomab satetraxetan on cell cycle and cell death in RIVA cells. Results showed that combination treatment significantly increased cell death and formation of multinucleated cells. PMC6897291

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.68mL

2.54mL

1.27mL

25.36mL

5.07mL

2.54mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories